Laporan Laba Rugi (TTM)
Laporan Laba Rugi Zylox-Tonbridge Medical Technology Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 28 | 62 | 97 | 137 | 178 | 219 | 259 | 297 | 334 | 373 | 411 | 470 | 528 | 596 | 664 | 723 | 782 | 840 | 898 |
Change (%) | 125.54 | 55.66 | 41.70 | 29.43 | 22.84 | 18.59 | 14.45 | 12.63 | 11.58 | 10.38 | 14.13 | 12.38 | 12.87 | 11.40 | 8.96 | 8.22 | 7.41 | 6.90 | |
% of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Cost Of Sales | 11 | 20 | 29 | 38 | 46 | 55 | 64 | 73 | 81 | 93 | 104 | 123 | 143 | 166 | 188 | 205 | 223 | 239 | 256 |
Change (%) | 78.59 | 44.01 | 28.89 | 22.41 | 19.45 | 16.28 | 13.67 | 12.03 | 13.64 | 12.01 | 18.88 | 15.88 | 15.97 | 13.77 | 9.08 | 8.33 | 7.59 | 7.05 | |
% of Revenue | 41.06 | 32.51 | 30.08 | 27.36 | 25.87 | 25.16 | 24.67 | 24.50 | 24.37 | 24.82 | 25.19 | 26.23 | 27.05 | 27.79 | 28.38 | 28.42 | 28.45 | 28.49 | 28.53 |
Gross Operating Profit | 16 | 42 | 68 | 100 | 132 | 164 | 195 | 224 | 253 | 280 | 308 | 346 | 385 | 430 | 475 | 518 | 560 | 601 | 642 |
Change (%) | 158.24 | 61.28 | 47.21 | 32.07 | 24.02 | 19.37 | 14.71 | 12.82 | 10.92 | 9.84 | 12.53 | 11.14 | 11.72 | 10.49 | 8.90 | 8.18 | 7.34 | 6.84 | |
% of Revenue | 58.94 | 67.49 | 69.92 | 72.64 | 74.13 | 74.84 | 75.33 | 75.50 | 75.63 | 75.18 | 74.81 | 73.77 | 72.95 | 72.21 | 71.62 | 71.58 | 71.55 | 71.51 | 71.47 |
SG&A | 51 | 85 | 119 | 158 | 196 | 207 | 219 | 234 | 249 | 261 | 272 | 275 | 278 | 277 | 276 | 271 | 266 | 275 | 283 |
Change (%) | 65.97 | 39.75 | 32.08 | 24.29 | 5.80 | 5.48 | 7.07 | 6.60 | 4.55 | 4.35 | 1.06 | 1.05 | -0.31 | -0.31 | -1.88 | -1.92 | 3.32 | 3.21 | |
% of Revenue | 186.19 | 137.01 | 123.00 | 114.66 | 110.10 | 94.83 | 84.34 | 78.90 | 74.68 | 69.97 | 66.15 | 58.57 | 52.66 | 46.51 | 41.62 | 37.48 | 33.97 | 32.67 | 31.55 |
R&D | 72 | 83 | 94 | 131 | 168 | 191 | 213 | 223 | 233 | 252 | 270 | 266 | 261 | 246 | 232 | 232 | 233 | 243 | 253 |
Change (%) | 14.93 | 12.99 | 39.81 | 28.47 | 13.40 | 11.82 | 4.76 | 4.55 | 7.87 | 7.30 | -1.71 | -1.73 | -5.61 | -5.94 | 0.32 | 0.32 | 4.30 | 4.12 | |
% of Revenue | 260.81 | 132.91 | 96.48 | 95.19 | 94.48 | 87.23 | 82.25 | 75.28 | 69.88 | 67.56 | 65.67 | 56.56 | 49.46 | 41.36 | 34.92 | 32.15 | 29.81 | 28.94 | 28.19 |
OpEx | 125 | 180 | 235 | 316 | 396 | 437 | 479 | 518 | 558 | 599 | 640 | 661 | 683 | 680 | 684 | 708 | 723 | 759 | 795 |
Change (%) | 44.15 | 30.63 | 34.16 | 25.46 | 10.42 | 9.44 | 8.25 | 7.62 | 7.35 | 6.84 | 3.42 | 3.31 | -0.54 | 0.70 | 3.43 | 2.13 | 4.96 | 4.73 | |
% of Revenue | 452.29 | 289.07 | 242.57 | 229.66 | 222.63 | 200.12 | 184.67 | 174.66 | 166.90 | 160.57 | 155.42 | 140.84 | 129.47 | 114.09 | 103.13 | 97.90 | 92.40 | 90.29 | 88.45 |
Operating Income | -97 | -118 | -138 | -178 | -218 | -219 | -219 | -221 | -224 | -226 | -228 | -192 | -156 | -84 | -21 | 15 | 60 | 82 | 104 |
Change (%) | 21.04 | 17.38 | 28.87 | 22.40 | 0.29 | 0.29 | 0.93 | 0.92 | 1.02 | 1.01 | -15.90 | -18.90 | -46.03 | -75.28 | -173.13 | 292.06 | 37.18 | 27.10 | |
% of Revenue | -352.29 | -189.07 | -142.57 | -129.66 | -122.63 | -100.12 | -84.67 | -74.66 | -66.90 | -60.57 | -55.42 | -40.84 | -29.47 | -14.09 | -3.13 | 2.10 | 7.60 | 9.71 | 11.55 |
Interest Expense | -1 | -0 | -0 | -0 | -0 | -0 | -1 | -1 | -1 | -1 | -1 | -0 | -2 | -2 | -1 | ||||
Change (%) | -26.35 | -35.78 | -1.27 | -1.29 | 55.21 | 35.57 | 5.88 | 5.56 | -5.96 | -6.33 | -22.80 | 25.78 | -59.01 | ||||||
% of Revenue | -2.41 | -0.79 | -0.32 | -0.23 | -0.17 | -0.22 | -0.25 | -0.23 | -0.22 | -0.18 | -0.15 | -0.10 | -0.28 | -0.32 | -0.12 | ||||
Net Income | -100 | -118 | -135 | -168 | -200 | -178 | -155 | -135 | -114 | -119 | -124 | -101 | -79 | -27 | 26 | 63 | 100 | 126 | 153 |
Change (%) | 17.38 | 14.80 | 23.75 | 19.19 | -11.07 | -12.45 | -13.48 | -15.58 | 4.41 | 4.22 | -18.14 | -22.16 | -66.29 | -196.61 | 145.47 | 59.26 | 26.10 | 20.70 | |
% of Revenue | -363.61 | -189.23 | -139.56 | -121.88 | -112.24 | -81.26 | -59.99 | -45.35 | -33.99 | -31.80 | -30.03 | -21.54 | -14.92 | -4.46 | 3.86 | 8.71 | 12.81 | 15.04 | 16.98 |
Source: Capital IQ